CLAYTON, Mo., Oct. 20, 2017 -- FutureFuel Corp. (NYSE:FF) ("FutureFuel"), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release third quarter 2017 financial results after market close on Thursday, November 9, 2017.
About FutureFuel
FutureFuel is a leading manufacturer of diversified chemical products and biofuels. FutureFuel's chemicals segment manufactures specialty chemicals for specific customers ("custom manufacturing”) as well as multi-customer specialty chemicals ("performance chemicals"). FutureFuel’s custom manufacturing product portfolio includes a laundry detergent additive, proprietary agrochemicals, adhesion promoters, a biocide intermediate, and an antioxidant precursor. FutureFuel's performance chemicals products include a portfolio of proprietary nylon and polyester polymer modifiers and several small-volume specialty chemicals and solvents for diverse applications. FutureFuel’s biofuels segment primarily produces and sells biodiesel to its customers. Please visit www.futurefuelcorporation.com for more information.
COMPANY CONTACT:
FutureFuel Corp.
Tom McKinlay
(314) 854-8352
www.futurefuelcorporation.com


Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 



